on Drägerwerk AG & Co. KGaA (ETR:DRW8)
Drägerwerk AG & Co. KGaA Reports Record Performance in 2025
Drägerwerk AG & Co. KGaA announced exceptional performance in fiscal year 2025, featuring strong order growth and record net sales. Orders totaled EUR 3,569 million, exceeding the previous year's figures significantly due to increased demand across both medical and safety divisions.
Net sales reached EUR 3,482 million, driven by growth in both divisions and all geographic regions. The company achieved substantial earnings gains, with EBIT rising by 20.3% to EUR 233.4 million despite challenges from tariffs and currency effects.
The dividend increased for the third consecutive year, with proposed payouts of EUR 2.21 per common share and EUR 2.27 per preferred share. This reflects the company's policy of a significant distribution of net profits while maintaining a strong equity ratio.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Drägerwerk AG & Co. KGaA news